Stay updated on Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.
Latest updates to the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoNo Change Detected
- Check47 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check54 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check67 days agoChange DetectedThe value 'Results First Posted (Estimated) Last Update Posted (Estimated)' has been updated to 'Results First Posted Last Update Posted'. This change indicates that the estimated labels have been removed from the results and last update posting dates on the webpage.SummaryDifference0.1%
- Check68 days agoChange DetectedThe value for Joanne Jeter has recently changed to Terminated Sponsor decision, indicating a change in the status of the study involving Nivolumab in preventing colon adenomas in participants with Lynch syndrome and a history of partial colectomy.SummaryDifference7%
Stay in the know with updates to Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Colon Adenomas in Lynch Syndrome Clinical Trial page.